315 results
8-K
EX-99.1
ALNY
Alnylam Pharmaceuticals Inc
2 Aug 18
Alnylam Pharmaceuticals Reports Second Quarter 2018 Financial Results and Highlights Recent Period Activity
8:15am
compensation expense and gain on litigation settlement. See “Use of Non-GAAP Financial Measures” below for a description of non-GAAP financial measures … release.
Gain on Litigation Settlement
In April 2018, we and Dicerna Pharmaceuticals, Inc. entered into a settlement agreement and general release
8-K
EX-99.1
ALNY
Alnylam Pharmaceuticals Inc
20 Apr 18
Alnylam Reaches Settlement Agreement with Dicerna Pharmaceuticals Resolving Trade
12:00am
)
617-551-8276
Alnylam Reaches Settlement Agreement with Dicerna Pharmaceuticals Resolving Trade
Secret Misappropriation and Other Pending Litigation … asserted by Dicerna, in pending litigation in the Superior Court of Middlesex County, Massachusetts. The settlement also resolves claims asserted by Dicerna
8-K
df6249c
15 Mar 11
Entry into a Material Definitive Agreement
12:00am
8-K
ewdujhiffb3pn
13 Nov 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
itor l562ulzje1opofe
6 Feb 20
Results of Operations and Financial Condition
8:28am
8-K
EX-99.1
04df9al8o6
31 Oct 19
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
e9x04im9j4
13 Nov 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
p8nu10ueby1x9472
7 Feb 19
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Recent Period Activity
4:15pm
8-K
EX-99.1
u01bc
6 Aug 19
Results of Operations and Financial Condition
8:15am
8-K
EX-99.1
f8iorjb9
9 Apr 19
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-99.1
uaumrun0iogt9yzo07ji
7 Nov 18
Alnylam Pharmaceuticals Reports Third Quarter 2018 Financial Results and Highlights Recent Period Activity
8:16am